Arvia Eleanor Morris

USPTO Granted Patents = 23 (Patent Applications = 9)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 6)

Average Co-Inventor Count = 3.0

ph-index = 6

Forward Citations = 246(Granted Patents)

Company Filing History:

Years Active: 1999-2023

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11827692 - Mammalian cell culture (2023-11-28),

2. 11685772 - Mammalian cell culture (2023-06-27),

3. 11673941 - Mammalian cell culture (2023-06-13),

4. 11634476 - Mammalian cell culture (2023-04-25),

5. 11292829 - Mammalian cell culture (2022-04-05),

6. 9587026 - Anti-interleukin-4 receptor antibodies (2017-03-07),

7. 9388447 - Method for culturing mammalian cells to improve recombinant protein production (2016-07-12),

8. 9228168 - Feed media (2016-01-05),

9. 9133493 - Method for culturing mammalian cells to improve recombinant protein production (2015-09-15),

10. 9012178 - Dipeptides to enhance yield and viability from cell cultures (2015-04-21),

11. 8679487 - Anti-interleukin-4 receptor antibodies (2014-03-25),

12. 8053236 - Feed media (2011-11-08),

13. 7166445 - Methods and host cells for improved cell culture (2007-01-23),

14. 7091004 - Regulation of translation for recombinant protein production (2006-08-15),

15. 6897040 - Methods and host cells for improved cell culture (2005-05-24),

Title: The Innovations of Arvia Eleanor Morris in Mammalian Cell Culture

Introduction: Arvia Eleanor Morris is a prominent inventor based in Seattle, WA, who has made significant contributions to the field of biotechnology. With a total of 23 patents to her name, Morris has focused her research on improving methods for culturing mammalian cells, thereby facilitating advancements in various biological applications.

Latest Patents: Among her notable patents, Morris has developed innovative techniques for mammalian cell culture. Her latest inventions provide a method that allows for greater control over cell growth, which leads to high product titer cell cultures. This advancement not only enhances production efficiency but also contributes to the overall effectiveness of biological research and therapeutic development.

Career Highlights: Throughout her career, Arvia Eleanor Morris has worked with renowned companies in the biotechnology sector, including Immunex Corporation and Amgen Inc. These positions have allowed her to apply her inventive insights to real-world challenges, furthering the advancement of biotechnological methods and applications.

Collaborations: Morris has collaborated with several talented professionals during her career, including Rebecca E. McCoy and Richard Jeffrey Armitage. Through these partnerships, they have explored innovative solutions and pushed the boundaries of research in cell culture techniques, significantly impacting the field.

Conclusion: Arvia Eleanor Morris exemplifies the spirit of innovation in biotechnology, with her extensive patent portfolio and impactful career. Her methods for mammalian cell culture represent a significant leap forward, enabling greater control and efficiency in biological research. As she continues her work, the contributions of Morris will undoubtedly influence future inventions and breakthroughs in the biotechnology sector.

This text is generated by artificial intelligence and may not be accurate.